| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/18/2010 | EP2217619A1 Cyclic, cystein-free protein |
| 08/18/2010 | EP2217614A1 Antimicrobial compositions, formulations and uses thereof |
| 08/18/2010 | EP2217266A2 A method for treating ailments of the oral cavity with a krill enzyme composition |
| 08/18/2010 | EP2217265A2 Modified insulin polypeptides and their uses |
| 08/18/2010 | EP2217264A2 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 08/18/2010 | EP2217263A2 Compositions and methods for treatment of microbial disorders |
| 08/18/2010 | EP2217262A2 C-terminal ifapsoriasin fragments as antimicrobial peptides, the production thereof and use thereof |
| 08/18/2010 | EP2217260A2 Amphiphilic peptide matrices for treatment of osteoporosis |
| 08/18/2010 | EP2217259A2 Methods for treatment of thiol-containing compound deficient conditions |
| 08/18/2010 | EP2217258A1 Methods of using interleukin-1 receptor antagonist as a myeloprotective agent |
| 08/18/2010 | EP2217211A1 An orally-absorbed solid dose formulation for vancomycin |
| 08/18/2010 | EP2217202A2 Oral care product and methods of use and manufacture thereof |
| 08/18/2010 | EP1626983B1 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| 08/18/2010 | EP1597275B1 Use of the Chlamydia pneumoniae CPn0104 polypeptide or antibodies thereto to diagnose Chlamydia infections |
| 08/18/2010 | EP1556068B1 Oxytocin for use in the treatment of Autism and Asperger's disorder |
| 08/18/2010 | EP1530636B1 Treatment of melanoma by reduction in clusterin levels |
| 08/18/2010 | EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 08/18/2010 | EP1417222B1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope |
| 08/18/2010 | EP1392321B1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 08/18/2010 | EP1390521B1 Glycopeptide antibiotics |
| 08/18/2010 | EP1140009B2 Absorbent article composition and use thereof for sequestering skin irritants. |
| 08/18/2010 | EP1036163B1 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 08/18/2010 | EP0910246B1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents |
| 08/18/2010 | EP0723402B1 Senescent cell-derived inhibitors of dna synthesis |
| 08/18/2010 | CN1729018B G-CSF conjugates |
| 08/18/2010 | CN1704121B Anti-angiogenic compositions and methods of use |
| 08/18/2010 | CN101809027A selective inhibitors of neurotensin degrading enzymes |
| 08/18/2010 | CN101808664A Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 08/18/2010 | CN101808662A Composition and method for treatment of autoimmune disease |
| 08/18/2010 | CN101808655A Peptides derived from plasminogen activator inhibitor-1 and uses thereof |
| 08/18/2010 | CN101808621A Oral pharmaceutical desmopressin composition |
| 08/18/2010 | CN101808532A prevention of allergy at weaning |
| 08/18/2010 | CN101805784A Single nucleotide polymorphism of human WNK4 genes and application thereof |
| 08/18/2010 | CN101805738A Peculiar p53 mutated protein-p53N236S of ALT tumor caused by progeria syndrome and application thereof |
| 08/18/2010 | CN101805408A Antitumor and thrombolytic double-effect chimeric protein, preparation method thereof and use thereof |
| 08/18/2010 | CN101805396A Anti-opioid peptide antagonist peptide and use thereof |
| 08/18/2010 | CN101805395A Polypeptide with inhibiting virus mixed infection activity |
| 08/18/2010 | CN101805393A REPLIKIN peptides and uses thereof |
| 08/18/2010 | CN101805392A Anti-inflammatory antibacterial polypeptide capable of blocking combination of LPS and MD2 |
| 08/18/2010 | CN101804200A Broad spectrum anti-viral therapeutics and prophylaxis |
| 08/18/2010 | CN101804199A Pharmaceutical composition used for alimentary canals and application thereof |
| 08/18/2010 | CN101804198A Combination containing fotemustine |
| 08/18/2010 | CN101804197A Medicament compound for treating cancer bone metastasis and purposes thereof |
| 08/18/2010 | CN101804196A Soybean-based whole protein type enteral nutrition powder and preparation method thereof |
| 08/18/2010 | CN101804195A Medicinal simulation calculus bovis and manufacturing method thereof |
| 08/18/2010 | CN101804194A CTLA4lg and derivatives thereof used for resisting bacteria |
| 08/18/2010 | CN101804193A CTLA4lg and derivatives thereof used for resisting viruses |
| 08/18/2010 | CN101804192A CTLA4lg and derivatives thereof used for resisting tumors |
| 08/18/2010 | CN101804026A Preparation of interferon fat emulsion for injection |
| 08/18/2010 | CN101407792B Preparation of pit viper bioactivity enzyme |
| 08/18/2010 | CN101240028B Conjugate constructed from normal pentadecyl and RGD peptide, and its synthesis and application in medicine |
| 08/18/2010 | CN101229362B Use of thymulin on preparing protective medicine of antineoplastic agent, tumour physiatry and chemotherapeutic medicine |
| 08/18/2010 | CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/17/2010 | US7779020 Small-footprint applicative query interpreter method, system and program product |
| 08/17/2010 | US7777069 Prodrugs of carbamate inhibitors of IMPDH |
| 08/17/2010 | US7777018 CDR-grafted anti-tissue factor antibodies and methods of use thereof |
| 08/17/2010 | US7777014 double-stranded decoy oligonucleotide; atherosclerosis; acts as a competitive inhibitor (or rather neutralisation) of a natural core-binding sequence of a DNA-binding protein or protein complex thereby blocks the expression of the eNOS |
| 08/17/2010 | US7777011 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy |
| 08/17/2010 | US7777010 Recovering preferential protein from library; obtain genetically engineered cells, transform with vector coding preferential protein, express protein, isolate protein |
| 08/17/2010 | US7777002 Sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution |
| 08/17/2010 | US7777001 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies |
| 08/17/2010 | US7777000 Anti-viral activity of cathelicidin peptides |
| 08/17/2010 | US7776999 Arsenic complexes; transmetallization |
| 08/17/2010 | US7776907 Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 08/17/2010 | US7776863 administering therapeutically effective amount of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine or salt thereof, with at least one other agent used for treatment of AIDS or HIV such as didanosine, delavirdine, ritonavir, enfuvirtide |
| 08/17/2010 | US7776837 RNA aptamers and methods for identifying the same |
| 08/17/2010 | US7776836 RNA aptamers and methods for identifying the same |
| 08/17/2010 | US7776834 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 08/17/2010 | US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin |
| 08/17/2010 | US7776828 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production |
| 08/17/2010 | US7776827 increases differentiation of high proliferative potential-stem and progenitor cells, colony forming cells-granulocyte, erythroid, macrophage, megakaryocyte cells, granulocyte-macrophage-colony forming cells, megakaryocyte-colony forming cells, T-lymphocytes; refractory anemia |
| 08/17/2010 | US7776826 Method for fostering bone formation and preservation |
| 08/17/2010 | US7776825 Mutant polypeptides of fibroblast growth factor 1 |
| 08/17/2010 | US7776824 neutrophil gelatinase-associated lipocalin (NGAL); siderophore coadministration to enhance secretion |
| 08/17/2010 | US7776823 antiinflammatories, antiviral agents; coadministering with antibiotic; surface decontamination |
| 08/17/2010 | US7776822 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy |
| 08/17/2010 | US7776821 A nanofilter with porosity about 20 nm used without marked loss of functional activity and a high recovery; nanofiltered MBL product, derived from plasma or recombinantly produced, is ready for preparing a drug for treatment of infections in patients with mannans- binding lectin defects |
| 08/17/2010 | US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs |
| 08/17/2010 | US7776819 Covalently conjugating a modified peptide to a PEGylated lipid to form a conjugate; inserting the conjugate into a carrier for the compound wherein the carrier has surface ligands specific for opioid receptor; repair-specific delivery of analgesics and/or alleviate side effects associated with opioids |
| 08/17/2010 | US7776817 coadministering tissue plasminogen activator, serum albumin, antidote, anticonvulsant; for damage caused by stroke, inflammation or organophosphate neurotoxins |
| 08/17/2010 | US7776816 by prophylactically administering Stromal Derived Factor 1 Alpha before hypoxia induces cell death; cell-free |
| 08/17/2010 | US7776815 calcitonin gene-related peptide, cholecystokinin, dynorphin, enkephalin, galanin, neuropeptide Y, neurotensin, somatostatin, substance P, thyrotropin-releasing hormone, vasoactive intestinal peptide |
| 08/17/2010 | US7776814 with cyclodextrins, polyoxyethylene glycol; anticancer agents |
| 08/17/2010 | US7776607 determining a human subject's susceptibility to developing colon or head and neck cancer by determining a genotype of a mammalian 15 kDa selenoprotein gene; selenium containing protein for use in diagnosis, prevention and treatment prostate cell proliferative disorders |
| 08/17/2010 | US7776598 Methods and compositions for polypeptide engineering |
| 08/17/2010 | US7776595 Ex vivo gene therapy of HIV infection; CD34+ hematopoietic cells being transduced with a viral construct which expresses an anti-HIV agent |
| 08/17/2010 | US7776579 detoxifying a pathogenic prion protein by bringing a surface which may be contaminated with a pathogenic prion protein into contact with an enzyme exhibiting an activity of digesting a protein highly resistant to denaturation and degradation |
| 08/17/2010 | US7776577 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase |
| 08/17/2010 | US7776572 Applying a coating solution comprising nonionic surfactant to the hydrophobic surface; drying the coated hydrophobic surface of to remove the solvent from the coating solution and thereby bind nonionic surfactant to the hydrophobic surface |
| 08/17/2010 | US7776560 Human tumor necrosis factor receptor TR9 antibody |
| 08/17/2010 | US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/17/2010 | US7776546 Using immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics |
| 08/17/2010 | US7776545 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal |
| 08/17/2010 | US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH) |
| 08/17/2010 | US7776364 N-acetyl-L-carnosine, carnosine, glutathione and cysteine in amounts which, when taken together, are effective to chemically reduce the amount of free radicals which would normally be found in vivo in the eye |
| 08/17/2010 | US7776361 NELL-1 enhanced bone mineralization |
| 08/17/2010 | US7776344 for extending clinical utility of interferon (IFN) alpha in treatment of a variety of viral and proliferative disorders; increase efficacy of IFN- alpha and reduce IFN- alpha treatment-related side effects |
| 08/17/2010 | US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 08/17/2010 | US7776337 novel lactic acid-producing strains; Lactobacillus acidophilus; for use in therapeutic feeds, reducing levels of colonization by target bacteria in poultry |
| 08/17/2010 | US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |